Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative DCE-MRI as a Predictor of Therapeutic Response in Acute Leukemia

NCT01537159 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT01537159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative DCE-MRI as a Predictor of Therapeutic Response in Acute Leukemia
Lead sponsor
OHSU Knight Cancer Institute
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2018
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia